Mirum Pharmaceuticals Ownership 2024 | Who Owns Mirum Pharmaceuticals Now?
Institutional Ownership
113.17%
Insider Ownership
2.28%
Retail Ownership
-15.45%
Institutional Holders
164.00
Mirum Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 13.84% | 10.39% | 6,495,392 | - | - | 222,077,452 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 10.63% | 0.09% | 4,988,747 | 2,221,537 | 80.28% | 170,557,599 | Jun 30, 2024 |
| BVF INC/IL | 9.31% | 4.19% | 4,370,024 | - | - | 149,411,121 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 7.70% | 2.12% | 3,614,820 | 314,420 | 9.53% | 123,590,696 | Jun 30, 2024 |
| BLACKROCK INC. | 6.90% | 0.00% | 3,238,049 | 785,776 | 32.04% | 110,708,894 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.21% | 0.00% | 2,446,733 | 235,048 | 10.63% | 83,653,801 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 3.78% | 1.82% | 1,772,038 | -84,526 | -4.55% | 60,585,979 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 3.20% | 2.98% | 1,500,000 | - | - | 51,285,000 | Jun 30, 2024 |
| STATE STREET CORP | 3.19% | 0.00% | 1,496,217 | -1,326,255 | -46.99% | 51,155,659,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.74% | 4.48% | 1,287,107 | 100,000 | 8.42% | 44,006,188 | Jun 30, 2024 |
| CADIAN CAPITAL MANAGEMENT, LP | 2.63% | 2.10% | 1,235,121 | -1,057,446 | -46.13% | 42,228,787 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.56% | 0.00% | 1,199,220 | -398,286 | -24.93% | 41,003,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.01% | 0.01% | 941,570 | 196 | 0.02% | 32,192,278 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.93% | 0.00% | 907,180 | 210,041 | 30.13% | 31,022,787 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.86% | 0.03% | 875,113 | -80,801 | -8.45% | 29,920,113 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.62% | 0.00% | 759,018 | 58,902 | 8.41% | 25,950,826 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.58% | 0.15% | 741,049 | 116,049 | 18.57% | 25,336,465 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.56% | 1.06% | 731,104 | -411,746 | -36.03% | 24,996,446 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 1.50% | 3.91% | 703,398 | -255,256 | -26.63% | 24,049,178 | Jun 30, 2024 |
| CLEARBRIDGE INVESTMENTS, LLC | 1.49% | 0.02% | 699,933 | 436,349 | 165.54% | 23,930,696 | Jun 30, 2024 |
Mirum Pharmaceuticals's largest institutional shareholder is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., holding 13.84% of the company's total share outstanding, currently valued at $222.08M. The top 10 institutional shareholders own together 66.51% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 13.84% | 10.39% | 6,495,392 | - | - | 222,077,452 | Jun 30, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 1.12% | 4.67% | 523,679 | 71,781 | 15.88% | 17,904,585 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.74% | 4.48% | 1,287,107 | 100,000 | 8.42% | 44,006,188 | Jun 30, 2024 |
| BVF INC/IL | 9.31% | 4.19% | 4,370,024 | - | - | 149,411,121 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 1.50% | 3.91% | 703,398 | -255,256 | -26.63% | 24,049,178 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.23% | 3.87% | 106,100 | 10,000 | 10.41% | 3,627,559 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.67% | 3.22% | 314,800 | -150,200 | -32.30% | 10,763,012 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 3.20% | 2.98% | 1,500,000 | - | - | 51,285,000 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.10% | 2.80% | 45,000 | - | - | 1,538,550 | Jun 30, 2024 |
| HIGHLANDER PARTNERS, L.P. | 0.26% | 2.80% | 122,980 | - | - | 4,204,686 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 1.05% | 2.62% | 492,569 | 492,569 | 100.00% | 16,840,934 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 7.70% | 2.12% | 3,614,820 | 314,420 | 9.53% | 123,590,696 | Jun 30, 2024 |
| CADIAN CAPITAL MANAGEMENT, LP | 2.63% | 2.10% | 1,235,121 | -1,057,446 | -46.13% | 42,228,787 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 3.78% | 1.82% | 1,772,038 | -84,526 | -4.55% | 60,585,979 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.14% | 1.61% | 64,000 | -30,000 | -31.91% | 2,188,160 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.16% | 1.57% | 75,200 | -47,800 | -38.86% | 2,571,088 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.56% | 1.06% | 731,104 | -411,746 | -36.03% | 24,996,446 | Jun 30, 2024 |
| ARDSLEY ADVISORY PARTNERS LP | 0.38% | 0.90% | 180,000 | -65,000 | -26.53% | 6,154,200 | Jun 30, 2024 |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 0.51% | 0.78% | 241,151 | -4,545 | -1.85% | 8,256,003 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.17% | 0.64% | 79,194 | - | - | 2,707,643 | Jun 30, 2024 |
The largest Mirum Pharmaceuticals shareholder by % of total assets is FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The company owns 6.50M shares of Mirum Pharmaceuticals (MIRM), representing 10.39% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10.63% | 0.09% | 4,988,747 | 2,221,537 | 80.28% | 170,557,599 | Jun 30, 2024 |
| BLACKROCK INC. | 6.90% | 0.00% | 3,238,049 | 785,776 | 32.04% | 110,708,894 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.08% | 0.11% | 508,475 | 508,475 | 100.00% | 17,383,949 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 1.05% | 2.62% | 492,569 | 492,569 | 100.00% | 16,840,934 | Jun 30, 2024 |
| CLEARBRIDGE INVESTMENTS, LLC | 1.49% | 0.02% | 699,933 | 436,349 | 165.54% | 23,930,696 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 7.70% | 2.12% | 3,614,820 | 314,420 | 9.53% | 123,590,696 | Jun 30, 2024 |
| INVESCO LTD. | 0.61% | 0.00% | 284,045 | 245,024 | 627.93% | 9,711,498 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.21% | 0.00% | 2,446,733 | 235,048 | 10.63% | 83,653,801 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.93% | 0.00% | 907,180 | 210,041 | 30.13% | 31,022,787 | Jun 30, 2024 |
| MORGAN STANLEY | 1.15% | 0.00% | 541,022 | 186,434 | 52.58% | 18,497,570 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.58% | 0.15% | 741,049 | 116,049 | 18.57% | 25,336,465 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.74% | 4.48% | 1,287,107 | 100,000 | 8.42% | 44,006,188 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.87% | 0.00% | 407,119 | 95,934 | 30.83% | 13,919,398 | Jun 30, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 1.12% | 4.67% | 523,679 | 71,781 | 15.88% | 17,904,585 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.62% | 0.00% | 759,018 | 58,902 | 8.41% | 25,950,826 | Jun 30, 2024 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 0.47% | 0.05% | 220,490 | 57,673 | 35.42% | 7,538,553 | Jun 30, 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.44% | 0.06% | 677,939 | 50,667 | 8.08% | 23,178,734 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.30% | 0.00% | 143,000 | 46,506 | 48.20% | 4,889,170 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.10% | 0.01% | 45,849 | 45,849 | 100.00% | 1,567,577 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.29% | 0.44% | 134,250 | 42,000 | 45.53% | 4,590,008 | Jun 30, 2024 |
As of Jun 30 2024, Mirum Pharmaceuticals's largest institutional buyer is JANUS HENDERSON GROUP PLC. The company purchased 2.22M stocks of MIRM, valued at $170.56M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.19% | 0.00% | 1,496,217 | -1,326,255 | -46.99% | 51,155,659,000 | Jun 30, 2024 |
| CADIAN CAPITAL MANAGEMENT, LP | 2.63% | 2.10% | 1,235,121 | -1,057,446 | -46.13% | 42,228,787 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.56% | 1.06% | 731,104 | -411,746 | -36.03% | 24,996,446 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.56% | 0.00% | 1,199,220 | -398,286 | -24.93% | 41,003,000 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | - | - | - | -362,193 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.57% | 0.00% | 265,443 | -274,223 | -50.81% | 9,075,496 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 1.50% | 3.91% | 703,398 | -255,256 | -26.63% | 24,049,178 | Jun 30, 2024 |
| ELEQUIN SECURITIES, LLC | - | - | - | -245,696 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -241,498 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -208,000 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.15% | 0.01% | 68,858 | -197,404 | -74.14% | 2,354,255 | Jun 30, 2024 |
| AXA S.A. | 0.91% | 0.04% | 425,992 | -167,794 | -28.26% | 14,564,666 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -151,002 | -100.00% | - | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.67% | 3.22% | 314,800 | -150,200 | -32.30% | 10,763,012 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.05% | 0.00% | 23,832 | -121,728 | -83.63% | 814,816 | Jun 30, 2024 |
| ABRDN PLC | - | - | - | -109,758 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.11% | 0.00% | 50,743 | -106,168 | -67.66% | 1,734,903 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.07% | 0.07% | 34,885 | -87,572 | -71.51% | 1,192,718 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 3.78% | 1.82% | 1,772,038 | -84,526 | -4.55% | 60,585,979 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.86% | 0.03% | 875,113 | -80,801 | -8.45% | 29,920,113 | Jun 30, 2024 |
As of Jun 30 2024, Mirum Pharmaceuticals's biggest institutional seller is STATE STREET CORP. The company sold -1.33M shares of MIRM, valued at $51.16B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CANDRIAM S.C.A. | 1.08% | 0.11% | 508,475 | 508,475 | 100.00% | 17,383,949 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 1.05% | 2.62% | 492,569 | 492,569 | 100.00% | 16,840,934 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.08% | 0.13% | 39,363 | 39,363 | 100.00% | 1,345,821 | Jun 30, 2024 |
| PENSERRA CAPITAL MANAGEMENT LLC | 0.06% | 0.01% | 26,906 | 26,906 | 100.00% | 920,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 22,244 | 22,244 | 100.00% | 760,522 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 21,104 | 21,104 | 100.00% | 721,546 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 683,800 | Jun 30, 2024 |
| GOLDEN STATE EQUITY PARTNERS | 0.04% | 0.14% | 19,930 | 19,930 | 100.00% | 681,407 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 15,608 | 15,608 | 100.00% | 530,838 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.04% | 15,245 | 15,245 | 100.00% | 521,227 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.09% | 14,417 | 14,417 | 100.00% | 492,917 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.03% | 0.22% | 12,369 | 12,369 | 100.00% | 422,896 | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | 0.02% | 0.27% | 11,252 | 11,252 | 100.00% | 384,706 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.02% | 0.29% | 10,780 | 10,780 | 100.00% | 368,568 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 10,477 | 10,477 | 100.00% | 358,208 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.01% | 0.02% | 6,503 | 6,503 | 100.00% | 222,000 | Jun 30, 2024 |
| MASSMUTUAL TRUST CO FSB/ADV | 0.00% | 0.00% | 74 | 74 | 100.00% | 2,530,000 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 48 | 48 | 100.00% | 2,000 | Jun 30, 2024 |
| COVESTOR LTD | - | 0.00% | 23 | 23 | 100.00% | 1,000 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | 20 | 20 | 100.00% | 680 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | 3 | 3 | 100.00% | 102 | Jun 30, 2024 |
Mirum Pharmaceuticals's largest new institutional shareholder by number of shares is CANDRIAM S.C.A., purchased 508.48K shares, valued at $17.38M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CHECKPOINT CAPITAL L.P. | - | - | - | -362,193 | -100.00% | - | Jun 30, 2024 |
| ELEQUIN SECURITIES, LLC | - | - | - | -245,696 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -241,498 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -208,000 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -151,002 | -100.00% | - | Jun 30, 2024 |
| ABRDN PLC | - | - | - | -109,758 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -79,018 | -100.00% | - | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | - | - | - | -70,000 | -100.00% | - | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -70,000 | -100.00% | - | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | - | - | - | -67,500 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | - | - | - | -59,800 | -100.00% | - | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | - | - | - | -41,836 | -100.00% | - | Jun 30, 2024 |
| UTAH RETIREMENT SYSTEMS | - | - | - | -19,577 | -100.00% | - | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -18,455 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -17,122 | -100.00% | - | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -14,812 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -14,309 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -12,583 | -100.00% | - | Jun 30, 2024 |
| ADVENT CAPITAL MANAGEMENT /DE/ | - | - | - | -12,500 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,196 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -12,153 | -100.00% | - | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | - | - | - | -10,764 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -10,016 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -7,199 | -100.00% | - | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | - | - | - | -3,012 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,887 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -2,721 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -1,668 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,445 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
| BEAR MOUNTAIN CAPITAL, INC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -74 | -100.00% | - | Jun 30, 2024 |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | - | - | - | -35 | -100.00% | - | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
Mirum Pharmaceuticals's largest sold out institutional shareholder by shares sold is CHECKPOINT CAPITAL L.P., sold -0.36M shares, valued at -, as of undefined.
Mirum Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ADVENT CONVERTIBLE & INCOME FUND | 0.91% | 3,130,000 | 2,177,000 | 228.44% | Jan 31, 2024 |
| TRI-CONTINENTAL CORP | 0.65% | 3,500,000 | - | - | Mar 31, 2024 |
| PUTNAM CONVERTIBLE SECURITIES FUND | 0.40% | 1,940,000 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.39% | 17,324 | 11,590 | 202.13% | Feb 29, 2024 |
| BUFFALO FUNDS | 0.30% | 2,000,000 | - | - | Mar 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.26% | 510,000 | -405,000 | -44.26% | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.25% | 605,000 | -475,000 | -43.98% | Jan 31, 2024 |
| Franklin Investors Securities Trust | 0.24% | 16,500,000 | - | - | Jan 31, 2024 |
| FRANKLIN VALUE INVESTORS TRUST | 0.24% | 890,567 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.22% | 445,000 | -345,000 | -43.67% | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.15% | 772,989 | 268,274 | 53.15% | Mar 31, 2024 |
| Virtus Convertible & Income Fund II | 0.15% | 555,000 | -430,000 | -43.65% | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.14% | 705,000 | -540,000 | -43.37% | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.12% | 2,160,000 | - | - | Feb 29, 2024 |
| Virtus Strategy Trust | 0.10% | 2,120,000 | -4,390,000 | -67.43% | Mar 28, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.09% | 76,190 | 76,190 | - | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.09% | 10,839,000 | - | - | Mar 31, 2024 |
| OBERWEIS FUNDS | 0.08% | 77,400 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 33,568 | 33,568 | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.05% | 126,478 | - | - | Jan 31, 2024 |
| MAINSTAY FUNDS | 0.04% | 10,000,000 | 3,319,000 | 49.68% | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.04% | 19,840 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 19,537 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.04% | 312,590 | 76,400 | 32.35% | Jan 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.04% | 6,863 | - | - | Mar 28, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.03% | 93,100 | 93,100 | - | Mar 31, 2024 |
| WASATCH FUNDS TRUST | 0.02% | 177,313 | - | - | Mar 31, 2024 |
| RBB Fund Trust | 0.01% | 12,892 | -189 | -1.44% | Feb 29, 2024 |
| Columbia Funds Series Trust II | 0.01% | 5,000,000 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.01% | 251 | -70 | -21.81% | Dec 31, 2023 |
| AB CAP FUND, INC. | 0.01% | 384,683 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 43,659 | -1,633 | -3.61% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 9,430 | -1,309 | -12.19% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,550 | -275 | -7.19% | Mar 31, 2024 |
| LEGG MASON PARTNERS VARIABLE EQUITY TRUST | 0.00% | 18,600 | 18,600 | - | Dec 29, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,845,366 | -873,546 | -32.13% | Mar 31, 2024 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.00% | 188,293 | 159,393 | 551.53% | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 32,878 | - | - | Mar 28, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 15,765 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 13,100 | - | - | Mar 28, 2024 |
| ALPS ETF Trust | 0.00% | 34,137 | -2,522 | -6.88% | Feb 29, 2024 |
| NEXPOINT FUNDS I | 0.00% | 10,000 | - | - | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.00% | 793,740 | 426,449 | 116.11% | Dec 31, 2023 |
| WILLIAM BLAIR FUNDS | 0.00% | 197,790 | 9,640 | 5.12% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 5,399 | -175 | -3.14% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 4,256 | -8,148 | -65.69% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 75,042 | 2,444 | 3.37% | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 114,328 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 392 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 366,056 | 72,892 | 24.86% | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.00% | 348,000 | - | - | Jan 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 156,721 | - | - | Jan 31, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 70,000 | - | - | Mar 28, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,000 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 13,710 | 6,195 | 82.44% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 10,844 | 1,504 | 16.10% | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,637 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 29,258 | -2,143 | -6.82% | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 4,000 | 4,000 | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 10,597 | 475 | 4.69% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 125,148 | 17,351 | 16.10% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 67,306 | -76,229 | -53.11% | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 7,700 | - | - | Mar 28, 2024 |
| Chartwell Funds | 0.00% | 16,431 | - | - | Jun 30, 2022 |
| MUTUAL FUND SERIES TRUST | 0.00% | 3,008,135 | 676,254 | 29.00% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,491 | -2,368 | -18.42% | Mar 31, 2024 |
| PUTNAM FUNDS TRUST | 0.00% | 100,400 | - | - | Jan 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 18,000 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 13,190 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 25,702 | -43,009 | -62.59% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 102,202 | 63,549 | 164.41% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,999 | -410 | -7.58% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 7,949 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 11,149 | - | - | Mar 28, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.00% | 4,269 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 2,315 | - | - | Aug 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 197,172 | 40,024 | 25.47% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,278 | - | - | Mar 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 311,000 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 25,370 | - | - | Feb 29, 2024 |
| Global X Funds | 0.00% | 11,793 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.00% | 5,000 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 8,201 | -2,015 | -19.72% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 57,218 | 54,230 | 1814.93% | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 960,000 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,146 | -124 | -9.76% | Mar 31, 2024 |
| TIFF INVESTMENT PROGRAM | 0.00% | 10,266 | 1,452 | 16.47% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 11,891 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 950,000 | - | - | Mar 31, 2024 |
| Virtus Investment Trust | 0.00% | 6,361 | - | - | Mar 28, 2024 |
| Harbor ETF Trust | 0.00% | 786 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 23,878 | -554 | -2.27% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 2,250,000 | - | - | Jan 31, 2024 |
| North Square Investments Trust | 0.00% | 1,241 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,400 | 300 | 3.70% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VIII | 0.00% | 11,201 | 10,898 | 3596.70% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 290,690 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 43 | - | - | Apr 30, 2021 |
| FundVantage Trust | 0.00% | 1,243 | - | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 1,189,055 | -28,067 | -2.31% | Mar 31, 2024 |
Mirum Pharmaceuticals's largest mutual fund holder by % of total assets is "ADVENT CONVERTIBLE & INCOME FUND", owning 3.13M shares, compromising 0.91% of its total assets.
Mirum Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 164 | -5.75% |
| 31 Mar, 24 | 174 | -8.42% |
| 31 Dec, 23 | 190 | 19.50% |
| 30 Sep, 23 | 159 | 8.16% |
| 30 Jun, 23 | 147 | 25.64% |
| 31 Mar, 23 | 117 | 13.59% |
| 31 Dec, 22 | 103 | -8.04% |
| 30 Sep, 22 | 112 | 3.70% |
| 30 Jun, 22 | 108 | 4.85% |
| 31 Mar, 22 | 103 | 15.73% |
| 31 Dec, 21 | 89 | 15.58% |
| 30 Sep, 21 | 77 | 14.93% |
| 30 Jun, 21 | 67 | 9.84% |
| 31 Mar, 21 | 61 | -14.08% |
| 31 Dec, 20 | 71 | 42.00% |
| 30 Sep, 20 | 50 | -12.28% |
| 30 Jun, 20 | 57 | 32.56% |
| 31 Mar, 20 | 43 | 7.50% |
| 31 Dec, 19 | 40 | 2.56% |
| 30 Sep, 19 | 39 | - |
As of 30 Jun 24, 164 institutions are holding Mirum Pharmaceuticals's shares, representing a decrease of -5.75% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 53,108,361 | -0.23% |
| 31 Mar, 24 | 53,228,863 | 6.43% |
| 31 Dec, 23 | 50,012,606 | 2.71% |
| 30 Sep, 23 | 48,693,333 | 31.20% |
| 30 Jun, 23 | 37,112,639 | 7.05% |
| 31 Mar, 23 | 34,669,431 | 4.01% |
| 31 Dec, 22 | 33,332,002 | -1.60% |
| 30 Sep, 22 | 33,874,125 | 15.51% |
| 30 Jun, 22 | 29,326,800 | 9.37% |
| 31 Mar, 22 | 26,813,355 | 8.06% |
| 31 Dec, 21 | 24,812,544 | 6.19% |
| 30 Sep, 21 | 23,365,701 | -0.16% |
| 30 Jun, 21 | 23,403,252 | 0.13% |
| 31 Mar, 21 | 23,373,102 | -1.75% |
| 31 Dec, 20 | 23,789,706 | 26.92% |
| 30 Sep, 20 | 18,743,135 | -0.35% |
| 30 Jun, 20 | 18,808,518 | 1.10% |
| 31 Mar, 20 | 18,603,243 | 14.47% |
| 31 Dec, 19 | 16,250,951 | -1.44% |
| 30 Sep, 19 | 16,487,773 | - |
Mirum Pharmaceuticals (MIRM) has 53.11M shares outstanding as of 30 Jun 24, down -0.23% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 113.17% | 0.88% |
| 31 Mar, 24 | 113.43% | 0.99% |
| 31 Dec, 23 | 107.04% | 0.76% |
| 30 Sep, 23 | 118.48% | 1.25% |
| 30 Jun, 23 | 97.39% | 1.15% |
| 31 Mar, 23 | 92.02% | 1.13% |
| 31 Dec, 22 | 90.19% | 0.96% |
| 30 Sep, 22 | 96.98% | 1.17% |
| 30 Jun, 22 | 91.18% | 1.24% |
| 31 Mar, 22 | 85.68% | 1.28% |
| 31 Dec, 21 | 81.83% | 1.38% |
| 30 Sep, 21 | 76.94% | 1.29% |
| 30 Jun, 21 | 77.31% | 1.28% |
| 31 Mar, 21 | 77.64% | 0.87% |
| 31 Dec, 20 | 94.21% | 1.69% |
| 30 Sep, 20 | 74.58% | 1.32% |
| 30 Jun, 20 | 75.07% | 1.32% |
| 31 Mar, 20 | 75.30% | 1.45% |
| 31 Dec, 19 | 71.95% | 0.86% |
| 30 Sep, 19 | 91.62% | - |
As of 30 Jun 24, Mirum Pharmaceuticals is held by 113.17% institutional shareholders, representing a 0.88% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 90 | -4.26% |
| 31 Mar, 24 | 94 | -18.97% |
| 31 Dec, 23 | 116 | 18.37% |
| 30 Sep, 23 | 98 | 1.03% |
| 30 Jun, 23 | 97 | 49.23% |
| 31 Mar, 23 | 65 | 6.56% |
| 31 Dec, 22 | 61 | -6.15% |
| 30 Sep, 22 | 65 | -4.41% |
| 30 Jun, 22 | 68 | 33.33% |
| 31 Mar, 22 | 51 | - |
| 31 Dec, 21 | 51 | 34.21% |
| 30 Sep, 21 | 38 | 22.58% |
| 30 Jun, 21 | 31 | 3.33% |
| 31 Mar, 21 | 30 | -37.50% |
| 31 Dec, 20 | 48 | 128.57% |
| 30 Sep, 20 | 21 | -41.67% |
| 30 Jun, 20 | 36 | 24.14% |
| 31 Mar, 20 | 29 | 7.41% |
| 31 Dec, 19 | 27 | -30.77% |
| 30 Sep, 19 | 39 | - |
90 institutional shareholders have increased their position in MIRM stock as of 30 Jun 24 compared to 94 in the previous quarter (a -4.26% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 50 | -3.85% |
| 31 Mar, 24 | 52 | 1.96% |
| 31 Dec, 23 | 51 | 59.38% |
| 30 Sep, 23 | 32 | 14.29% |
| 30 Jun, 23 | 28 | -3.45% |
| 31 Mar, 23 | 29 | 16.00% |
| 31 Dec, 22 | 25 | -10.71% |
| 30 Sep, 22 | 28 | 27.27% |
| 30 Jun, 22 | 22 | -26.67% |
| 31 Mar, 22 | 30 | 57.89% |
| 31 Dec, 21 | 19 | -9.52% |
| 30 Sep, 21 | 21 | -8.70% |
| 30 Jun, 21 | 23 | 43.75% |
| 31 Mar, 21 | 16 | 33.33% |
| 31 Dec, 20 | 12 | -36.84% |
| 30 Sep, 20 | 19 | 137.50% |
| 30 Jun, 20 | 8 | 60.00% |
| 31 Mar, 20 | 5 | -28.57% |
| 31 Dec, 19 | 7 | - |
| 30 Sep, 19 | - | - |
50 institutional shareholders have reduced their position in MIRM stock as of 30 Jun 24 compared to 52 in the previous quarter (a -3.85% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 164 | -5.75% | 53,108,361 | -0.23% | 113.17% | 0.88% | 90 | -4.26% | 50 | -3.85% |
| 31 Mar, 24 | 174 | -8.42% | 53,228,863 | 6.43% | 113.43% | 0.99% | 94 | -18.97% | 52 | 1.96% |
| 31 Dec, 23 | 190 | 19.50% | 50,012,606 | 2.71% | 107.04% | 0.76% | 116 | 18.37% | 51 | 59.38% |
| 30 Sep, 23 | 159 | 8.16% | 48,693,333 | 31.20% | 118.48% | 1.25% | 98 | 1.03% | 32 | 14.29% |
| 30 Jun, 23 | 147 | 25.64% | 37,112,639 | 7.05% | 97.39% | 1.15% | 97 | 49.23% | 28 | -3.45% |
| 31 Mar, 23 | 117 | 13.59% | 34,669,431 | 4.01% | 92.02% | 1.13% | 65 | 6.56% | 29 | 16.00% |
| 31 Dec, 22 | 103 | -8.04% | 33,332,002 | -1.60% | 90.19% | 0.96% | 61 | -6.15% | 25 | -10.71% |
| 30 Sep, 22 | 112 | 3.70% | 33,874,125 | 15.51% | 96.98% | 1.17% | 65 | -4.41% | 28 | 27.27% |
| 30 Jun, 22 | 108 | 4.85% | 29,326,800 | 9.37% | 91.18% | 1.24% | 68 | 33.33% | 22 | -26.67% |
| 31 Mar, 22 | 103 | 15.73% | 26,813,355 | 8.06% | 85.68% | 1.28% | 51 | - | 30 | 57.89% |
| 31 Dec, 21 | 89 | 15.58% | 24,812,544 | 6.19% | 81.83% | 1.38% | 51 | 34.21% | 19 | -9.52% |
| 30 Sep, 21 | 77 | 14.93% | 23,365,701 | -0.16% | 76.94% | 1.29% | 38 | 22.58% | 21 | -8.70% |
| 30 Jun, 21 | 67 | 9.84% | 23,403,252 | 0.13% | 77.31% | 1.28% | 31 | 3.33% | 23 | 43.75% |
| 31 Mar, 21 | 61 | -14.08% | 23,373,102 | -1.75% | 77.64% | 0.87% | 30 | -37.50% | 16 | 33.33% |
| 31 Dec, 20 | 71 | 42.00% | 23,789,706 | 26.92% | 94.21% | 1.69% | 48 | 128.57% | 12 | -36.84% |
| 30 Sep, 20 | 50 | -12.28% | 18,743,135 | -0.35% | 74.58% | 1.32% | 21 | -41.67% | 19 | 137.50% |
| 30 Jun, 20 | 57 | 32.56% | 18,808,518 | 1.10% | 75.07% | 1.32% | 36 | 24.14% | 8 | 60.00% |
| 31 Mar, 20 | 43 | 7.50% | 18,603,243 | 14.47% | 75.30% | 1.45% | 29 | 7.41% | 5 | -28.57% |
| 31 Dec, 19 | 40 | 2.56% | 16,250,951 | -1.44% | 71.95% | 0.86% | 27 | -30.77% | 7 | - |
| 30 Sep, 19 | 39 | - | 16,487,773 | - | 91.62% | - | 39 | - | - | - |
Mirum Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Mirum Pharmaceuticals's stock was made by Peetz Christopher on Jul 24 2024, selling 34,013 shares at $2.94 per share (valued at $99.86K).
Mirum Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 3 | 66.67% |
| Q2 2024 | 21 | 4 | 525.00% |
| Q1 2024 | 18 | 13 | 138.46% |
| Q4 2023 | 5 | 2 | 250.00% |
| Q3 2023 | 10 | 10 | 100.00% |
| Q2 2023 | 35 | 32 | 109.38% |
| Q1 2023 | 8 | 4 | 200.00% |
| Q4 2022 | 6 | 3 | 200.00% |
| Q2 2022 | 21 | 8 | 262.50% |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 8 | 6 | 133.33% |
| Q3 2021 | 7 | 4 | 175.00% |
| Q2 2021 | 13 | - | - |
| Q1 2021 | 7 | 1 | 700.00% |
| Q4 2020 | 13 | 2 | 650.00% |
| Q2 2020 | 7 | 1 | 700.00% |
| Q1 2020 | 9 | - | - |
| Q4 2019 | 1 | 1 | 100.00% |
| Q3 2019 | 52 | 33 | 157.58% |
2 total buy trades, and 3 total sell trades (buy/sell ratio of 0.67%) were made by Mirum Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 2 | - |
| Q1 2024 | 2 | 11 | 18.18% |
| Q4 2023 | 1 | 1 | 100.00% |
| Q3 2023 | 5 | 7 | 71.43% |
| Q2 2023 | - | 2 | - |
| Q1 2023 | - | 4 | - |
| Q4 2022 | - | 3 | - |
| Q2 2022 | - | 7 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 3 | 6 | 50.00% |
| Q3 2021 | - | 4 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 5 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 2 | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 33 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Mirum Pharmaceuticals's stocks.
Mirum Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| KALV | KalVista Pharmaceuticals, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| IMCR | Immunocore Holdings plc |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| ARQT | Arcutis Biotherapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| MLTX | MoonLake Immunotherapeutics |
| ABOS | Acumen Pharmaceuticals, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
MIRM Ownership FAQ
Who Owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals is owned by institutional shareholders (113.17%), insiders (2.28%), and public (-15.45%). The largest institutional shareholder of Mirum Pharmaceuticals is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. (13.84% of total shares) and the top mutual fund owner is ADVENT CONVERTIBLE & INCOME FUND (0.91% of total shares).
Who are the major institutional shareholders of Mirum Pharmaceuticals?
Mirum Pharmaceuticals's major institutional shareholders are FRAZIER LIFE SCIENCES MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, and BLACKROCK INC.. The top five shareholders own together 48.39% of the company's share outstanding.
How many Mirum Pharmaceuticals shareholders are there?
As of Jun 2024, there are 164 institutional shareholders of Mirum Pharmaceuticals.
What percentage of Mirum Pharmaceuticals is owned by FRAZIER LIFE SCIENCES MANAGEMENT, L.P?
FRAZIER LIFE SCIENCES MANAGEMENT, L.P owns 6.5M shares of Mirum Pharmaceuticals, representing 13.84% of the company's total shares outstanding, valued at $222.08M (as of Jun 2024).
What percentage of Mirum Pharmaceuticals is owned by JANUS HENDERSON GROUP PLC?
As of Jun 2024, JANUS HENDERSON GROUP PLC holds 4.99M shares of Mirum Pharmaceuticals (MIRM), compromising 10.63% of the company, valued at $170.56M.
What percentage of Mirum Pharmaceuticals is owned by BVF INC/IL?
BVF INC/IL is the third largest holder of Mirum Pharmaceuticals. The company owns 4.37M of the company's shares outstanding (worth $149.41M).